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Abstract  26 
 27 
Objective: Muscle co-activation has been shown to be elevated in individuals with knee 28 
osteoarthritis (KOA) during gait. Comparisons of muscle co-activation across different 29 
activities of daily living such as stair negotiation has yet to be explored. The aim of the study 30 
was to explore muscle co-activation across different activities of daily living in patients with 31 
KOA. 32 
 33 
Methods: Muscle co-activation was assessed in 77 symptomatic KOA participants (age 34 
62.5±8.1years; bodymass index 29.4±9.0kg/m
2
; gender 48/29 female/male) using 35 
electromyography (EMG), during a series of walking, stair negotiation (ascent, descent) and 36 
sit-to-walk activities. EMG was recorded from 7 sites, medial/lateral gastrocnemius, biceps 37 
femoris, semitendinosus, vastus lateralis/medialis and rectus femoris and normalised to 38 
maximal voluntary isometric contraction. Correlation was used to assess the consistency of 39 
co-activation across activities. Repeated measures ANOVA assessed the muscle combination 40 
by activity differences. 41 
 42 
Results: Muscle co-activation was highest during stair ascent. When comparing muscle 43 
combinations within the same activity correlations ranged from r=0.003-0.897 of which 80% 44 
of combinations were significant. Between activities muscle co-activation was significantly 45 
different (P<0.05). Medial:lateral muscle co-activation was higher than 46 
hamstrings:quadriceps across activities. 47 
 48 
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Conclusion: Two muscle co-activation strategies were observed during activities of daily 49 
living in patients with KOA to maintain stability. Muscle co-activation was higher during 50 
more challenging activities, particularly when the joint is accepting load. Medial:lateral 51 
muscle co-activation was higher than hamstrings:quadriceps whereby medial:lateral co-52 
activation is thought to be a stabilisation mechanism whilst hamstrings:quadriceps responds 53 
to knee flexion moments, suggesting different muscle combinations may have different 54 
roles in responding to joint demand. 55 
 56 
Keywords: osteoarthritis; co-activation; muscle; gait; stairs; activities of daily living;  57 
  58 
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Significance and Innovations 59 
• The same patients demonstrated consistently high or low muscle co-activity across all 60 
muscle combinations. 61 
• Muscle co-activation was significantly different across activities, whereby muscle co-62 
activation was higher during more challenging activities e.g. stair negotiation than less 63 
challenging activities e.g. gait. 64 
• Neither overall nor selective muscle co-activation strategies were prominent, whereby 65 
it appears both muscle co-activation strategies modulate in unison to promote joint 66 
stability.  67 
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Introduction  68 
 69 
Individuals with knee osteoarthritis (KOA) exhibit altered movement patterns (i.e. reduced 70 
knee flexion; altered knee stiffening) compared to healthy controls (1–6), as a result of 71 
structural changes, pain, muscle weakness and a loss of proprioception (7). Muscle 72 
activation is controlled by two mechanisms: feedforward based on cognitive control; and 73 
feedback responding to changes detected by joint receptors (mechanoreceptors; 74 
proprioceptors) (8). These altered movement patterns have been associated with high joint 75 
loads; loss of joint stability; and the inability of the musculature to provide stability (9–11). 76 
 77 
Muscle co-activation (simultaneous coordinated agonist and antagonist muscle activity) is 78 
thought to be a major mechanism for joint stabilisation, load distribution and movement 79 
control during gait in KOA (1–3,5–7,11–17). Baratta et al (9) suggested muscle co-activation 80 
is necessary to aid the ligaments in maintaining joint stability; distributing joint surface 81 
pressure and regulating joint mechanical impedance. In healthy young individuals and KOA, 82 
two muscle co-activation strategies have been identified. Overall muscle co-activation, is 83 
considered as high muscle co-activation across all muscle combinations surrounding the 84 
joint (18). Selective muscle co-activation involves high muscle co-activation in specific, but 85 
not all muscle combinations, (e.g. agonist:antagonist (2,3,18), or medial:lateral (3,19) 86 
combinations, but not both). In KOA high levels of muscle co-activation are thought to 87 
stabilise the knee in the absence of sufficient stabilisation from the passive-restraints 88 
system (20). This strategy has been associated with increased joint contact pressures and 89 
maybe a risk factor for cartilage degeneration and KOA disease progression (1–3,5,6,11–90 
14,20,21). 91 
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 92 
It is well established that during walking, individuals with KOA demonstrate higher muscle 93 
co-activation than controls (1,2,4,12,14–17,21) in anterior-posterior (1,2,12,14–17,21) and 94 
medio-lateral (1,17) muscle combinations. This has been reported during specific phases of 95 
gait (1,2,4,13,14,17,21) and the entire gait cycle (3–6,12,15,19,22).  Schmitt and Rudolph (1) 96 
found that as the knee prepares to accept and accepts weight, high anterior-posterior co-97 
activation stabilised the joint. During progression from double-limb to single-limb-support, 98 
the knee becomes increasingly unstable and high muscle co-activation across all muscle 99 
combinations is needed as a stabilisation mechanism (1). DeMont (23,24) also suggested 100 
control of the knee position during dynamic movement may be dependent on muscle 101 
activation prior to a stress occurring, emphasising the importance of exploring muscle co-102 
activation prior to heel strike during dynamic activities. For other activities of daily living 103 
(ADL) very little evidence of muscle co-activation in individuals with KOA exists. Two studies 104 
looking at stair negotiation found conflicting results. Childs et al. (2) found high tibialis 105 
anterior:gastrocnemius co-activation in individuals with KOA, whilst Hortobágyi, et al. (14) 106 
found there was no difference between KOA and controls. When activities were grouped, 107 
individuals with KOA had higher biceps femoris:vastus lateralis co-activation. Patsika et al. 108 
(25) found higher biceps femoris muscle activity and no difference in the vastus lateralis 109 
between individuals with KOA and controls during sit-to-stand. Bouchouras et al. (4) also 110 
found significantly higher biceps femoris:vastus lateralis co-activation during sit-to-stand 111 
compared to controls. In healthy individuals, it would be expected that during more 112 
challenging activities (i.e. stair negotiation) requiring higher muscle activation, muscle co-113 
activation would be higher. In individuals with neuromuscular deficits such as those with 114 
KOA, this may not be true. This may have implications for rehabilitation (i.e. limit tasks 115 
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which can be undertaken). It is therefore important to understand muscle co-activation 116 
strategies across different ADL and across different muscle combinations. 117 
 118 
It has been suggested that agonist:antagonist, especially hamstrings:quadriceps co-119 
activation increases joint stiffness, where it’s primary role is to influence anterior tibial shear 120 
force and internal rotation  (1,2,26–28). The vastii muscles have however been suggested to 121 
be general joint stabilisers  (26,27), whereby medial:lateral co-activation is thought to 122 
respond to joint space narrowing, and instability, increasing joint stiffness and joint load  123 
(2,3,26,27). This raises questions about co-activation in KOA. Specifically, do the same 124 
people consistently demonstrate the highest muscle co-activation across different activities 125 
and muscle groups (e.g. high positive correlation between agonist:antagonist and 126 
medial:lateral muscle co-activation across all activities)? Alternatively, do different 127 
individuals exhibit high muscle co-activation during different activities or muscle 128 
combinations (e.g. high medial:lateral and low agonist:antagonist muscle co-activation 129 
during stair negotiation, and low medial:lateral and high agonist:antagonist muscle co-130 
activation during gait).  131 
 132 
The purpose of this study was to explore muscle co-activation patterns across different ADL 133 
and investigate specific areas of muscle co-activation during different phases of gait. It was 134 
hypothesised that 1) for a specific activity, patients will demonstrate high muscle co-activity 135 
across all muscle combinations; 2) muscle co-activation will be higher in the medial:lateral 136 
than agonist:antagonist muscle combinations in patients with KOA; 3) muscle co-activation 137 
will be higher during more challenging activities (e.g. stair descent) compared to less 138 
challenging activities (e.g. gait). 139 
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 140 
Methods 141 
 142 
Participants 143 
 144 
Data analysis presented here is part of the NEKO study (NCT02314715, 145 
www.clinicaltrials.gov). A convenience sample of adults (40 years or over), with doctor-146 
diagnosed unilateral/bilateral KOA, with self-reported knee pain, stiffness lasting 147 
<30minutes and confirmed by ultrasound and/or magnetic resonance imaging (data not 148 
presented), were recruited through rheumatology clinics; general practitioner practices; and 149 
a local newspaper advert. Participants were excluded if they had any current neuromuscular 150 
skeletal injury or disease, knee replacement, knee surgery in the past year, steroid injections 151 
in the past 3 months or severe co-morbidity which would limit participation in the study. 152 
All participants gave written informed consent to participate in the study. The assessment 153 
protocol was approved by the West of Scotland Research Ethics Committee (ref 154 
13/WS/0146) and Glasgow Caledonian University (ref HLS12/86) and carried out in 155 
compliance with the Declaration of Helsinki. 156 
 157 
Electromyography and muscle co-activation 158 
 159 
Wireless surface electrodes (99% silver, 4 5x1mm bar ‘Trigno’ sensors, fixed inter-electrode 160 
distance 10mm, Delsys, Boston, USA) were placed over the belly of the vastus medialis 161 
(VM); rectus femoris (RF); vastus lateralis (VL); semitendinous (ST); biceps femoris (BF); 162 
medial and lateral gastrocnemius (MG; LG) muscles of the test leg (6,12,29). The test leg was 163 
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defined as the most symptomatic knee based on self-report. The electrode placement was 164 
in accordance with surface electromyography for the non-invasive assessment of muscles 165 
(SENIAM) recommendations (30,31). The area was shaved, lightly abraded and cleaned with 166 
alcohol. Isolated contractions assessed electromyography (EMG) recordings. The raw signal 167 
was passed through a Trigno differential amplifier, input impedance 10,000MΩ, CMRR 168 
>80dB, gain 1,000 with a bandwidth of 20Hz-450Hz. EMG signal was recorded with a 16-bit 169 
analogue-to-digital converter (PCI-DAS6402/16, Measurement computing corporation, 170 
Massachusetts, USA), at a sampling rate of 2400Hz. All EMG and force data were collected in 171 
Qualysis Track Manager (version 2.7-2.9, Qualysis Motion Capture Systems, Sweden) and 172 
processed in Spike2 (version 2.7.10, Cambridge Electronic Design Ltd, Cambridge, UK). 173 
 174 
Measures of activities of daily living 175 
 176 
Participants performed a series of ADL tasks in the following order; stair ascent and stair 177 
descent, walking, and sit-to-walk transitions, during a single visit to the human performance 178 
laboratory at Glasgow Caledonian University. The number of trials performed for each 179 
activity as stated in the protocol was a pragmatic decision to enable high-quality data to be 180 
collected while safeguarding patients against high levels of fatigue. 181 
 182 
Participants performed three stair ascent and descent trials using a four-step instrumented 183 
staircase with a force plate (Kistler, 9286BA, Switzerland) embedded in the second step, 184 
aligned with a second Kistler force plate in the walkway. Participants ascended the stairs, 185 
turned and descended, ensuring the test leg landed on both force plates (walkway and 186 
second step). A successful trial was defined as the entire foot landing within the boundaries 187 
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of the force plate with no obvious signs of targeting the plate. The use of handrails was 188 
permitted if required, step-over-step (alternate leg on each step) was preferred; however, 189 
when this was not possible step-by-step (both legs on the same step with test leg as lead 190 
leg) was permitted. 191 
 192 
Participants performed seven successful walking trials at a self-selected walking speed. A 193 
successful trial was defined as above and within ±10% of movement time (Brower timing 194 
system, Draper, Utah, USA).  195 
 196 
A standard armchair (height 48cm) was placed on the walkway next to the force plate. 197 
Participants sat with their back against the chair and test leg on the force plate, they were 198 
instructed to stand up, walk 3.6m before turning and returning to a seated position. The use 199 
of the chair arms was permitted if required. For the purpose of this analysis, the stance 200 
phase (onset of force to toe-off), from three sit-to-walk trials was used. 201 
 202 
For all activities, the stance phase was analysed, defined as initial contact (ground reaction 203 
force exceeded 20N) to toe-off (ground reaction force fell below 20N). During walking the 204 
stance phase was also split into four sub-phases; loading (0-14.9% of stance), early-stance 205 
(15-39.9%), mid-stance (40-59.9%) and late-stance (60-100%) with an additional pre-stance 206 
phase (-150ms to initial contact) (17). Stair ascent and descent were each split into two sub-207 
phases; walk-to-stair transition (stance on the floor force plate) and continuous (stance on 208 
the force plate embedded in the stairs). 209 
 210 
Page 11 of 49
John Wiley & Sons, Inc.
Arthritis Care & Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
12 
 
Participants performed a series of maximal voluntary isometric contractions (MVIC), using 211 
an isometric dynamometer (Biodex 4 Pro, Biodex Medical Systems Inc, New York, USA). 212 
Participants were seated with their knee and hip flexed at 50deg and 90deg respectively. 213 
Following a series of warm-up contractions, participants performed 3 flexion/extension 214 
MVIC’s lasting 3s with 30s rest for the hamstrings and quadriceps respectively. For the 215 
gastrocnemius participants were seated with their knee at full extension and foot in 216 
anatomically neutral. Following a series of warm-up contractions, participants performed a 217 
series of 3 plantarflexion MVIC’s lasting 3s with 30s rest. Data was analysed over a 500ms 218 
window: 250ms either side of peak force for hamstrings and quadriceps and 250ms either 219 
side of peak EMG amplitude for gastrocnemius.  220 
 221 
Symptom severity 222 
Participants completed the knee injury and osteoarthritis survey (KOOS) (32) and self-223 
reported the duration of their symptoms. 224 
 225 
Data Management 226 
 227 
EMG data was Butterworth 4
th
 order zero-lag bandpass filtered at 20-450Hz. The average 228 
root mean squared amplitude (RMSamp) was calculated for the stance phase, subsequent 229 
sub-phases defined above and normalised to MVIC RMSamp  (33–35). RMSamp was chosen as 230 
it is suggested to be more robust and directly linked to electrical power, having more 231 
physiological significance over linear envelope (33,36). MVIC’s were used for normalisation 232 
over peak dynamic amplitude because it is believed that MVIC’s provide an estimate of 233 
neuromuscular control and information about muscle activation enabling individual 234 
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variation which precludes direct comparison to be taken into account (33,34,36). In 235 
individuals with KOA normalisation to MVIC has been used to understand neuromuscular 236 
control alterations (3,35,37–39) and serves to provide a physiological reference (40). 237 
 238 
Muscle co-activation was calculated using RMSamp normalised to MVIC, normalised RMSamp 239 
data was used to calculate muscle co-activation using equation (1), where lowerEMGi and 240 
higherEMGi are respectively the lowest and highest RMSamp at sample i, division by 100 241 
takes the average across the normalised interval (41). Muscle co-activation strategies were 242 
explored using the following muscle groups: quadriceps ([Q] VL; RF; VM):gastrocnemius ([G] 243 
MG; LG); gastrocnemius(G):hamstrings ([H] ST; BF) hamstrings(H):quadriceps(Q); and medial 244 
([M] VM; ST; MG):lateral ([L] VL; BF; LG) and muscle pairs: VL:VM; ST:BF; MG:LG. Muscle 245 
groups involving multiple muscles, the mean RMS for the muscles involved was used. To 246 
explore agonist:antagonist versus medial:lateral muscle co-activation the following muscle 247 
combinations where used: H:Q and VL:VM. 248 
 249 
Co-activation Index = 
∑ lowerEMGi
higherEMGi
lowerEMGi+higherEMGi
100
i=1
100
  (1) 250 
 251 
Statistical Analysis 252 
 253 
Descriptive statistics including means, standard deviations, and frequencies of the 254 
demographics were determined. Skewness, kurtosis, and boxplots were obtained to 255 
examine the distribution and identify outliers for all variables. Hierarchical sensitivity 256 
analysis was performed with 1) all data; 2) extreme outliers (>3* interquartile range (IQR)) 257 
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removed; 3) all outliers (>1.5*IQR) removed; 4) all outliers and device users removed (‘valid 258 
data’); 5) valid data with 1.5*IQR outliers associated with low MVIC or pain during MVIC 259 
included. Device users were defined as individuals who used the stairs handrails and/or a 260 
walking-aid whilst performing the ADL tasks. Once extreme outliers were removed some 261 
variables remain insignificant whilst others became significantly different between 262 
individuals with KOA and controls (data not presented), this did not change when further 263 
outliers were removed (42). The main analysis was run with only extreme (3*IQR) outliers 264 
removed. Sensitivity analysis was performed with and without device users; there was no 265 
difference between device users and non-device users. 266 
 267 
Repeated measures ANOVA followed up with Bonferroni post hoc test was performed to 268 
compare muscle co-activity within each activity. Pearson’s correlations between muscle co-269 
activation combinations within the same activity, and partial correlations controlling for 270 
muscle strength and age assessed hypothesis 1 (muscle co-activation would be high across 271 
all muscle combinations within a given activity). Correlation strength was defined as r<0.1 272 
no association; r=0.1-0.29 weak; r=0.3-0.49 moderate; r>0.49 strong association (43). 273 
Hypothesis 2 (muscle co-activation will be higher in the medial:lateral than 274 
agonist:antagonist pairs) was assessed with paired sample T-Tests using VL:VM and H:Q 275 
combinations. The VL:VM co-activation provides a clear metric for medial:lateral co-276 
activation to provide neuromuscular control of the knee joint, as the vastii muscles were 277 
general joint stabilisers (26). Repeated measures ANOVA (muscle co-activation-by-activity) 278 
followed up with Bonferroni Post hoc test addressed hypothesis 3 (muscle co-activation will 279 
be higher during more challenging activities). All statistical analysis was conducted using 280 
SPSS (version 22.0 Chicago, USA) with alpha set at 0.05. 281 
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  282 
Results 283 
 284 
A total of 77 individuals with KOA were recruited from Rheumatology Clinics (N=15), general 285 
practitioner practices (n=4) and a local newspaper advert (N=58) (Table 1), 13 (17%) people 286 
had missing data for the stairs. 287 
 288 
Gait 289 
During gait, VL:VM demonstrated higher muscle co-activation than ST:BF during pre-stance, 290 
loading, early-stance, and MG:LG during loading. During mid-stance, late-stance and overall-291 
stance MG:LG was higher than ST:BF and VL:VM. Medial:lateral co-activation was higher 292 
than Q:G, G:H during pre-stance and loading; H:Q, G:H during early-stance, mid-stance, and 293 
overall-stance; H:Q, Q:G, G:H during late-stance (waveform data in supplement A). 294 
 295 
Within the same phase of walking, correlations between muscle co-activation combinations 296 
ranged from no-association to strong positive associations (Figure 1; Supplement B). Pre-297 
stance ranged from r=0.264 (P=0.025, ST:BF-VL:VM) to r=0.897 (P<0.001, H:G-Q:G), loading 298 
range from r=0.070 (P=0.557, H:G-VL:VM) to r=0.682 (P<0.001, H:Q-ST:BF) of which 87% of 299 
combinations were significant, for early-stance r=0.296 (P=0.011, H:Q-MG:LG) to r=0.739 300 
(P<0.001, H:G-H:Q), mid-stance ranged r=0.105 (P=0.374, MG:LG-VL:VM) to r=0.759 301 
(P<0.001, Q:G-VL:VM) of which 73% of combinations were significant, late-stance ranged 302 
from r=0.073 (P=0.547, H:Q-MG:LG) to r=0.708 (P<0.001, Q:G-VL:VM) of which 87% of 303 
combinations were significant, and overall-stance ranged from r=0.159 (P=0.191, H:Q-304 
MG:LG) to r=0.721 (P<0.001, H:Q-H:G and H:Q-ST:BF) of which 93% of combinations were 305 
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significant. The strength of the associations decreased when controlling for age and muscle 306 
strength. 307 
 308 
Muscle co-activation was significantly higher for VL:VM than H:Q for loading (P=0.008), 309 
early-stance (P<0.001), mid-stance (P<0.001), late-stance (P<0.001) overall-stance 310 
(P<0.001), there was no difference for pre-stance (P=0.319, Figure 2). 311 
 312 
Stair negotiation 313 
Medial:lateral gastrocnemius co-activation was higher than VL:VM during stair ascent 314 
transition (SUT), and continuous stair descent (SDC), while MG:LG and VL:VM were similar 315 
and higher than ST:BF during continuous stair ascent (SUC) and descent transition (SDT). 316 
Medial-lateral co-activation was higher than H:Q, H:G during SUT, SUC, and SDC; Q:G during 317 
SUT and SDT. During SDC Q:G was similar to H:G; M:L, and higher than H:Q. 318 
 319 
Within the same phase of stair negotiation, correlations across muscle co-activation ranged 320 
from no association to strong positive associations (Figure 1, supplement B). Stair ascent 321 
transition ranged from r=-0.004 (P=0.976, MG:LG-VL:VM) to r=0.850 (P<0.001, H:G-ST:BF) of 322 
which 60% of combinations were significant, SUC ranged from r=0.079 (P=0.548, Q:G-323 
MG:LG) to r=0.784 (P<0.001, H:G-H:Q) of which 60% of combinations were significant. 324 
During SDC correlations ranged from r=-0.006 (P=0.984, H:Q-MG:LG) to r=0.816 (P<0.001 325 
H:Q-ST:BF) with 60% of combinations significant, whilst SDT ranged from r=0.003 (P=0.984, 326 
ST;BF-MG:LG) to r=0.722 (P<0.001, H:Q-ST:BF) of which 60% of combinations were 327 
significant. The strength of the associations decreased when controlling for age and muscle 328 
strength. 329 
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 330 
Muscle co-activation was significantly higher for VL:VM than H;Q across all phases of stair 331 
negotiation (P<0.001; Figure 2). 332 
 333 
Sit-to-walk 334 
During sit-to-walk VL:VM demonstrated higher muscle co-activation than ST:BF and MG:LG, 335 
whilst M:L was higher than H:Q, Q:G and H:G. Sit-to-walk demonstrated a weak (r=0.251, 336 
P=0.032, H:Q-MG:LG) to strong associations (r=0.727, P<0.001, H:Q-H:G; Figure 1; 337 
Supplement B). Muscle co-activation was higher in VL:VM than H:Q (P<0.001) during sit-to-338 
walk (Figure 2). 339 
 340 
Muscle co-activation across activities 341 
Muscle co-activation was significantly different within the same muscle co-activation 342 
combination across activities and phases (P<0.001) for all muscle co-activation combinations 343 
(Figure 3). Muscle co-activation was significantly (P<0.05) different across 65.5% (H:Q); 344 
61.8% (H:G); 63.6% (Q:G); 70.9% (M:L); 74.5% (VL:VM); 47.2% (ST:BF); 72.7% (MG:LG) of 345 
activity combinations. Pre-stance was significantly different to loading; early-stance; overall-346 
stance; sit-to-walk and stair negotiation across all muscle combinations except ST:BF. Pre-347 
stance was significantly different to loading; mid-stance and late-stance for ST:BF. Mid-348 
stance and late-stance were different to loading; overall-stance; sit-to-walk for all muscle 349 
combinations. Overall-stance was different to sit-to-walk (H:G) and SUC (all combinations 350 
except H:G; ST:BF); sit-to-walk was different to SUC (all combinations except ST:BF) and stair 351 
ascent and descent phases were also different to each other for all combinations except 352 
ST:BF. 353 
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 354 
Discussion 355 
 356 
The results indicate that muscle co-activation was positively correlated across different 357 
muscle combinations within the same activity. Medio-lateral co-activation within the 358 
quadriceps was higher than anterior-posterior co-activation across all activities in KOA. 359 
Muscle co-activation was higher during more challenging activities (stair negotiation) than 360 
less challenging activities (gait).  361 
 362 
Investigations into muscle co-activation in KOA typically focus on walking. This study aimed 363 
to explore muscle co-activation across different ADL, during which different muscle co-364 
activation strategies were observed. Overall muscle co-activation was deployed when the 365 
limb is preparing to, and accepts weight and starts to transition towards single limb support. 366 
It appears that overall muscle co-activation is a strategy adopted when the limb is least 367 
stable, in more vulnerable positions requiring all muscles to activate simultaneously to 368 
stabilise the joint. During transitions from single-to-double limb support and when increased 369 
muscle force is required to propel the body from a flexed position into extension (mid-370 
stance and late-stance; sit-to-walk; stair ascent) selective muscle co-activation was utilised. 371 
Specifically high muscle co-activation in MG:LG and VL:VM which are thought to act as joint 372 
stabilisers, contribute towards rotational moments or increase compressive loads to 373 
facilitate moment generation needed to direct ground reaction forces, and potentially 374 
increase medial joint stability (11,26,27,44,45). Our results demonstrated neither overall nor 375 
selective muscle co-activation was prominent, with a combination of both strategies 376 
utilised. Mills et al. (11) a systematic review of 14 papers, highlighted that during walking 377 
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specific muscle co-activation is believed to play a role in distributing loads, whilst Lloyd and 378 
Buchanan (18) found in their modelling study that specific muscle co-activation (H:Q) 379 
contributed to muscular support in response to static valgus-varus loads. These results 380 
suggest that both muscle co-activation strategies are modulated throughout different 381 
phases of walking or other activities to increase joint stability; distribute joint loads and 382 
support joint moments at the potential cost of increased compressive loads. 383 
 384 
Within the same activity, the same patients demonstrated high or low muscle co-activity 385 
across all muscle combinations. With increasing age and the addition of joint space 386 
narrowing associated with KOA, the passive restraints (e.g. ligaments) become increasingly 387 
lax (39,44). To prevent lateral joint opening and the transfer of load medially higher 388 
antagonist muscle force is required (46). Higher antagonist muscle activation is thought to 389 
increase joint stiffness (46), however, the ability to adopt movement strategies which 390 
remain normal is lost with muscle weakness (39). Alterations in muscle co-activation 391 
strategies may therefore, try and accommodate this lack of joint stability. Individuals with 392 
selective high muscle co-activation may be at an increased risk of disease progression as a 393 
result of high joint loads combined with high joint pressures associated with high muscle co-394 
activation. 395 
 396 
VL:VM co-activation was higher than H:Q in individuals with KOA across all activities except 397 
pre-stance. H:Q co-activation increases joint stiffness to counteract joint instability (2). 398 
Hamstrings activation is thought to increase joint stiffness and reduce loads on the anterior 399 
cruciate ligament by reversing the shear force on the tibia counterbalancing the main knee 400 
flexion moment, at the expense of increased patellofemoral and tibiofemoral load (28). 401 
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VL:VM co-activation has been suggested to be a response to joint space narrowing, 402 
increased joint stiffness and joint surface loading (2,3,19,37,47). Flaxman et al., also 403 
identified the vastii muscles as general joint stabilisers bracing the knee (26,27). When 404 
combined with increased joint contact pressures associated with high muscle co-activation, 405 
this may increase the risk for cartilage degeneration (1–3,6,12–14,18,19,21). Hodges et al. 406 
(48) found that increased duration of medial (vastus medalis:semimembranosus) co-407 
activation was associated with medial cartilage loss in medial KOA, whilst Zeni et al (12) 408 
found high medial co-activation controlled medial laxity and instability in medial KOA. 409 
Lateral (vastus lateralis:biceps femoris) co-activation was inversely related with medial 410 
cartilage loss in KOA (48), and is thought to unload the medial compartment (3,6,15,17).  411 
According to findings from Bae et al (49), tibiofemoral OA is either confined to the medial 412 
compartment or generalized over the medial and lateral compartments. Several studies in 413 
medial and generalised KOA are in support of selective lateral activation (3,6,15,17), 414 
however, others do not  (1,44,45). These results appear to be consistent with medial and 415 
generalised KOA across the literature. Three studies investigated muscle co-activation and 416 
included medial KOA patients only, with mixed results. Rudolph et al (39) and Lewek et al 417 
(45) found higher medial activation whilst Lewek et al (37) demonstrated high lateral muscle 418 
co-activation. Including both medial and generalised KOA in this study may dilute any 419 
compartmental differences if they exist however further research is required to understand 420 
muscle co-activation differences between medial tibiofemoral and generalised disease.  421 
 422 
Muscle co-activation across activities was significantly different. It was hypothesised that 423 
muscle co-activation would be higher during more challenging activities such as stair 424 
negotiation compared to less challenging activities such as gait.  Muscle co-activation was 425 
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higher during stair negotiation than overall-stance and sit-to-walk, where overall-stance was 426 
higher than sit-to-walk. This is potentially due to a combination of greater joint instability 427 
and muscle force required to perform more challenging activities, whereby knee joint 428 
stability is required to propel the body up each step or control the lowering of the body 429 
down each step. During pre-stance the results demonstrated higher Q:G, and similar Q:H 430 
activity to Schmitt and Rudolph (1), where Q:G, G:H, and MG:LG are low whilst Q:G, M:L, 431 
VL:VM, ST:BF appear to be increasing in preparation to accept load (1,3) and slow the 432 
acceleration of the joint. During loading our results were higher compared to the literature, 433 
and higher than pre-stance except for MG:LG which is in keeping with the literature showing 434 
a peak in quadriceps activity (3,6). Additionally, high medial:lateral co-activation during 435 
loading was found which is similar to Heiden et al (17). During early-stance all combinations 436 
were lower than loading in line with Schmitt and Rudolph (1), whilst M:L remained higher 437 
than other combinations (17). During Mid- and late-stance no studies using the same 438 
equation MG:LG which increased, peaking during late-stance. Muscle co-activation was 439 
higher during sit-to-walk across all combinations compared to gait except for loading and 440 
overall-stance, stair ascent was higher than sit-to-walk and gait except for loading and 441 
overall stance. During continuous stair ascent muscle co-activation was higher than ascent 442 
transition for ST:BF and MG:LG. Muscle co-activation during stair descent was generally 443 
higher than gait and lower than continuous ascent and ascent. During more biomechanically 444 
challenging activities requiring greater muscle activation elevated co-activation is expected. 445 
This was shown in KOA patients in this study. 446 
 447 
This study has a number of strengths and limitations. Firstly it is a relatively large 448 
convenience sample (N=77) with substantial sensitivity analysis performed prior to and 449 
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during the statistical analysis. We did not screen or grade participants for radiographic 450 
disease severity making comparisons with previous literature difficult. MVIC’s were 451 
performed for the hamstrings and quadriceps however reference contractions were 452 
performed for the gastrocnemius to prevent discomfort to the patient. During stair 453 
negotiation and sit-to-walk transition participants were permitted to use the handrails, step-454 
by-step stair negotiation style, and chair arm. Whilst this showed muscle co-activation 455 
during normal daily living, this meant movement was not standardised across the entire 456 
sample. Sensitivity analysis indicated that this did not affect the results presented here. 457 
Other studies which looked at muscle co-activation during stair negotiation did not allow 458 
the use of handrails. Muscle co-activation was higher in the study participants compared to 459 
the values reported for individuals with KOA in the literature (2,15,37,38). It is unclear why 460 
muscle co-activation values where so high compared to the literature possible explanations 461 
include:  varying disease severity, participant demographics. Differences in signal processing 462 
as the studies which used the same equation and normalisation methods used linear 463 
envelope to process their data rather than RMS, whilst others used difference co-activation 464 
equations, normalisation methods, different time epochs over which the data was analysed. 465 
Alternatively, low muscle activation during MVIC as a result of not fully activating the 466 
musculature or really low muscle activation may elevate the normalised EMG. 467 
 468 
To conclude, muscle co-activation patterns appear to be high across all muscle combinations 469 
within the same activity. Higher muscle co-activation was observed during more challenging 470 
activities which require greater stability. Whilst neither overall nor selective muscle co-471 
activation was prominent it appears they modulate in unison to maintain joint stability and 472 
respond to the demands upon the joint. Whilst high muscle co-activation appears to be a 473 
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mechanism to maintain joint stability it may also increase the susceptibility of cartilage 474 
damage and risk of incidence and progression of KOA.   475 
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Figure legends 1 
Figure 1 Correlations of muscle co-activation for individuals with KOA within the same 2 
activity for A) Sit-to-walk VL:VM and H:Q (r
2
 =0.716**), B) Early-stance MG:LG and H:Q 3 
(r
2
=0.408**), C) Loading H:Q and VL:VM (r
2
=0.299*), D) Stairs continuous ascent MG:LG and 4 
HQ (r
2
=-0.094) *P<0.05 ** P<0.01. 5 
 6 
Figure 2 Muscle co-activation for vastus lateralis:medalis (Black) and hamstrings:quadriceps 7 
(Spotted) across different activities for individuals with KOA. Significant differences between 8 
medial:lateral and hamstrings:quadriceps *P<0.05; **P<0.01; †P<0.001. 9 
 10 
Figure 3 Muscle co-activation combinations during A) phases of walking B) activities of daily 11 
living for individuals with KOA 12 
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1 
 
Tables 1 
Table 1: Patient demographics and activities of daily living data presented 
as means (SD) 
Characteristic KOA (n = 77) 
Age, years 62.5 (8.1) 
Females, % 48 (62%) 
Height, m 1.66 (0.11) 
Body mass, kg 81.5 (19.4) 
BMI, kg/m
2
 29.4 (6.0) 
Duration of symptoms, yrs 9.3 (9.2) 
KOOS pain 56.8 (17.6) 
KOOS symptoms 54.7 (19.4) 
KOOS activities of daily living 65.2 (20.1) 
KOOS sports and recreation 33.8 (24.9) 
KOOS quality of life 39.1 (21.3) 
  
Activities of daily living  
Walking Speed, m/s 1.05 (0.15) 
Walking stick used, Yes (%) 2 (3%) 
Chair arm used, Yes (%) 53 (69%) 
Stairs walking styles (KOA=64 C=16)  
Ascent, SOS (%) 60 (94%) 
             SBS (%) 4 (6%) 
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2 
 
Descent, SOS (%) 56 (88%) 
               SBS (%) 8 (12%) 
Handrail used, Yes (%) 26 (41%) 
KOA = knee osteoarthritis; BMI = bodymass index; SOS = step-over-step; SBS = 
step-by-step; KOOS = knee injury and osteoarthritis outcome survey 
 2 
Page 38 of 49
John Wiley & Sons, Inc.
Arthritis Care & Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
 
1 
 
SUPPLEMENTARY MATERIAL 1 
  2 
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2 
 
Pre-stance Loading Early-stance Mid-stance Late-stance 
Supplement A. Waveform data for individual muscles, muscle groups, and muscle co-3 
activation during gait 4 
 5 
6 
7 
 8 
 9 
Figure S1. Mean (solid line) and standard deviation (shaded cloud) for individual quadriceps 10 
muscles A) vastus lateralis B) vastus medalis C) rectus femoris during gait 11 
A 
C 
B 
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3 
 
Pre-stance Loading Early-stance Mid-stance Late-stance 
12 
13 
14 
 15 
Figure S2. Mean (solid line) and standard deviation (shaded cloud) for individual hamstrings 16 
and gastrocnemius muscles A) biceps femors B) semitendinosus C) lateral gastrocnemius D) 17 
medial gastrocnemius during gait 18 
A 
B 
C 
D 
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4 
 
Pre-stance Loading Early-stance Mid-stance Late-stance 
19 
20 
 21 
 22 
Figure S3. Mean (solid line) and standard deviation (shaded cloud) for A) quadriceps B) 23 
hamstrings C) gastrocnemius muscle groups during gait. 24 
 25 
A 
C 
B 
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5 
 
Pre-stance Loading Early-stance Mid-stance Late-stance 
26 
 27 
Figure S4. Mean (solid line) and standard deviation (shaded cloud) for A) medial B) lateral 28 
muscle groups during gait. 29 
  30 
A 
B 
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6 
 
Pre-stance Loading Early-stance Mid-stance Late-stance 
31 
32 
 33 
Figure S5. Mean (solid line) and standard deviation (shaded cloud) for individual muscle co-34 
activation index combinations A) vastus lateralis:medalis B) semitendinosus:biceps femors 35 
C) medial:lateral gastrocnemius during gait. 36 
  37 
A 
C 
B 
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7 
 
Pre-stance Loading Early-stance Mid-stance Late-stance 
38 
39 
40 
 41 
Figure S5. Mean (solid line) and standard deviation (shaded cloud) for A) 42 
hamstrings:quadriceps B) quadriceps:gastrocnemius C) gastrocnemius:hamstrings D) 43 
medial:lateral muscle group co-activation combinations during gait. 44 
A 
B 
C 
D 
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8 
 
Supplement B Pearson’s correlation coefficients for comparison of muscle co-activation 45 
across muscle combinations within the same activity or phase for individuals with KOA. 46 
 47 
Table 1. Pearson’s correlation coefficients for Walk Pre-
stance *P<0.05; **P<0.01 
 
Q:G H:G VL:VM ST:BF MG:LG 
H:Q 0.549** 0.555** 0.544** 0.464** 0.477** 
Q:G   0.897** 0.472** 0.483** 0.635** 
H:G   0.474** 0.459** 0.640** 
VL:VM     0.264* 0.509** 
ST:BF     0.364** 
 48 
Table 2. Pearson’s correlation coefficients for Walk Loading 
*P<0.05; **P<0.01 
 
Q:G H:G VL:VM ST:BF MG:LG 
H:Q 0.441** 0.564** 0.299* 0.682** 0.303* 
Q:G  0.750** 0.518** 0.307** 0.560** 
H:G    0.070 0.415** 0.563** 
VL:VM    0.226 0.335** 
ST:BF      0.294* 
 49 
Table 3. Pearson’s correlation coefficients for Walk Early-
stance *P<0.05; **P<0.01 
 
Q:G H:G VL:VM ST:BF MG:LG 
H:Q 0.642** 0.739** 0.408** 0.550** 0.296* 
Q:G  0.557** 0.594** 0.305** 0.358** 
H:G    0.373** 0.651** 0.408** 
VL:VM    0.423** 0.295* 
ST:BF      0.364* 
 50 
Table 4. Pearson’s correlation coefficients for Walk Mid-
stance *P<0.05; **P<0.01 
 
Q:G H:G VL:VM ST:BF MG:LG 
H:Q 0.624** 0.740** 0.534** 0.671** 0.185 
Q:G   0.456** 0.759** 0.428** 0.228 
H:G   0.397** 0.743** 0.169 
VL:VM     0.465** 0.105 
ST:BF     0.231* 
 51 
  52 
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9 
 
Table 5. Pearson’s correlation coefficients for Walk Late-
stance *P<0.05; **P<0.01 
 
Q:G H:G VL:VM ST:BF MG:LG 
H:Q 0.552** 0.682** 0.533** 0.582** 0.073 
Q:G   0.364** 0.708** 0.302** 0.378** 
H:G   0.406** 0.616** 0.243* 
VL:VM     0.447** 0.265* 
ST:BF      0.079 
 53 
Table 6. Pearson’s correlation coefficients for Walk Overall-
stance *P<0.05; **P<0.01 
 
Q:G H:G VL:VM ST:BF MG:LG 
H:Q 0.676** 0.721** 0.364** 0.721** 0.159 
Q:G   0.599** 0.646** 0.466** 0.369** 
H:G 
 
  0.279* 0.706** 0.297* 
VL:VM    0.335** 0.371** 
ST:BF      0.276* 
 54 
Table 7. Pearson’s correlation coefficients for Sit-to-Walk 
*P<0.05; **P<0.01 
 
H:G Q:G VL:VM ST:BF MG:LG 
H:Q 0.727** 0.661** 0.716** 0.649** 0.251* 
H:G   0.704** 0.414** 0.721** 0.342** 
Q:G    0.533** 0.607** 0.364** 
VL:VM    0.435** 0.270* 
ST:BF      0.355** 
 55 
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Table 8. Pearson’s correlation coefficients for stair negotiation. UT- ascent transition; UC- ascent continuous; DC – descent continuous; DT – descent transition; *P<0.05; **P<0.01 
 
H:Q 
UC H:Q DC H:Q DT H:G UT H:G UC H:G DC H:G DT Q:G UT 
Q:G 
UC Q:G DC Q:G DT 
VL:VM 
UT 
VL:VM 
UC 
VL:VM 
DC 
VL:VM 
DT 
ST:BF 
UT 
ST:BF 
UC 
ST:BF 
DC 
ST:BF 
DT 
MG:LG 
UT 
MG:LG 
UC 
MG:LG 
DC 
MG:LG 
DT 
H:Q UT 0.671** 0.722** 0.795** 0.615** 0.621** 0.487** 0.411** 0.708** 0.654** 0.490** 0.621** 0.564** 0.453** 0.460** 0.513** 0.581** 0.450** 0.612** 0.537** 0.031 0.084 0.115 0.087 
H:Q UC  0.692** 0.788** 0.819** 0.784** 0.532** 0.550** 0.440** 0.540** 0.462** 0.411** 0.403** 0.359** 0.502** 0.308* 0.664** 0.686** 0.598** 0.564** -0.050 -0.094 0.016 -0.021 
H:Q DC    0.842** 0.721** 0.712** 0.698** 0.590** 0.496** 0.543** 0.418** 0.492** 0.427** 0.407** 0.434** 0.510** 0.547** 0.476** 0.816** 0.653** -0.097 -0.114 -0.006 0.001 
H:Q DT    0.790** 0.659** 0.613** 0.637** 0.621** 0.582** 0.609** 0.691** 0.585** 0.545** 0.574** 0.583** 0.568** 0.473** 0.732** 0.722** -0.068 -0.103 0.008 0.019 
H:G UT      0.846** 0.797** 0.807** 0.519** 0.557** 0.540** 0.496** 0.391** 0.346** 0.459** 0.376** 0.850** 0.668** 0.744** 0.722** 0.017 -0.138 0.049 0.103 
H:G UC      0.692** 0.647** 0.418** 0.532** 0.365** 0.375** 0.326** 0.252* 0.351** 0.330** 0.713** 0.639** 0.709** 0.603** -0.034 -0.116 0.015 0.042 
H:G DC        0.780** 0.416** 0.547** 0.483** 0.447** 0.171 0.215 0.196 0.224 0.677** 0.549** 0.690** 0.693** 0.064 0.011 0.098 0.161 
H:G DT        0.300* 0.386** 0.384** 0.414** 0.178 0.167 0.195 0.222 0.732** 0.563** 0.620** 0.710** 0.041 -0.079 0.163 0.190 
Q:G UT          0.597** 0.667** 0.794** 0.719** 0.622** 0.516** 0.628** 0.341** 0.214 0.477** 0.289* 0.058 -0.034 0.115 0.140 
Q:G UC          0.660* 0.594** 0.700** 0.711** 0.689** 0.610** 0.498** 0.344** 0.438** 0.495** -0.022 0.079 0.076 0.082 
Q:G DC            0.712** 0.593** 0.658** 0.640** 0.560** 0.488** 0.439** 0.500** 0.474** 0.323* 0.285* 0.234 0.333* 
Q:G DT            0.573** 0.534** 0.401** 0.557** 0.415** 0.286* 0.445** 0.443** 0.115 0.061 0.044 0.085 
VL:VM 
UT              0.795** 0.753** 0.868** 0.232 0.114 0.303* 0.326* -0.004 0.073 0.095 0.006 
VL:VM 
UC              0.888** 0.873** 0.053 -0.082 0.296* 0.179 0.149 0.154 0.165 0.176 
VL:VM 
DC                0.784** 0.237 0.183 0.318* 0.200 0.157 0.193 0.190 0.191 
VL:VM 
DT                0.234 0.105 0.394** 0.303* 0.098 0.099 0.125 0.159 
ST:BF 
UT                  0.823** 0.733** 0.813** 0.078 0.090 0.129 0.206 
ST:BF 
UC                   0.723** 0.723** 0.202 0.200 0.175 0.243 
ST:BF 
DC                   0.802** 0.026 -0.041 0.067 0.125 
ST:BF 
DT                     -0.076 0.012 -0.008 0.003 
MG:LG 
UT                      0.864** 0.736** 0.775** 
MG:LG 
UC                      0.705** 0.733** 
MG:LG 
DC                        0.754** 
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